Metformin (dimethyl-biguanide) induced DNA damage in mammalian cells

In vitro and in vivo anti-melanoma action of metformin

(2011) Kristina Janjetovic et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Accelerated carcinogenesis following liver regeneration is associated with chronic inflammation-induced double-strand DNA breaks

(2010) H. Barash et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission

(2009) H. A. Hirsch et al.   CANCER RESEARCH

Assessment of genomic instability in normal and diabetic rats treated with metformin

(2009) S.M. Attia et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Metformin Increases HDL3–Cholesterol and Decreases Subcutaneous Truncal Fat in Nondiabetic Patients with HIV-Associated Lipodystrophy

(2008) Leandro A. Diehl et al.   AIDS PATIENT CARE AND STDS

AMPK activation by long chain fatty acyl analogs

(2008) Ghadeer Za’tara et al.   BIOCHEMICAL PHARMACOLOGY

Metformin induces oxidative stress in white adipocytes and raises uncoupling protein 2 levels

(2008) Andrea Anedda et al.   JOURNAL OF ENDOCRINOLOGY

Basic Infertility Including Polycystic Ovary Syndrome

(2008) Maryse Brassard et al.   MEDICAL CLINICS OF NORTH AMERICA

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level

(2008) I Ben Sahra et al.   ONCOGENE